SABCS: Low-Dose Tamoxifen Cuts Risk for Breast Dz

THURSDAY, Dec. 6, 2018 -- Tamoxifen at a dose of 5 mg/day is associated with a reduced risk for recurrence for women with hormone-sensitive breast intraepithelial neoplasia, according to a study presented at the annual San Antonio Breast Cancer...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news